Turbine (Drug Discovery)
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Turbine (Drug Discovery) is currently valued at N/A as of November 1, 2025. The company has raised a total of $38.1M in funding.
Investment Perspective
Turbine (Drug Discovery)'s valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Turbine (Drug Discovery) Worth in 2025?
As of 2025, Turbine (Drug Discovery) is valued at N/A, based on the company's Later Stage VC funding round in November 1, 2025. This valuation positions Turbine (Drug Discovery) as one of the leading private companies in the sector.
Turbine (Drug Discovery) Valuation History
Turbine (Drug Discovery)'s funding history demonstrates steady growth and investor confidence.
How Turbine (Drug Discovery) Valuation is Determined
Private company valuations like Turbine (Drug Discovery)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Turbine (Drug Discovery) Valuation FAQs
Is Turbine (Drug Discovery) profitable?
Turbine (Drug Discovery) has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Turbine (Drug Discovery)'s valuation compare to competitors?
Turbine (Drug Discovery) is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Turbine (Drug Discovery) IPO?
Turbine (Drug Discovery) has not announced plans for an initial public offering. Until an IPO, investors can access Turbine (Drug Discovery) shares through secondary market platforms.